Breast Neoplasms

"Breast Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the human BREAST.

Descriptor ID	D001943
MeSH Number(s)	C04.588.180 C17.800.090.500
Concept/Terms	Breast Neoplasms Breast Neoplasms Breast Neoplasm Neoplasm, Breast Breast Tumors Breast Tumor Tumor, Breast Tumors, Breast Neoplasms, Breast Breast Carcinoma Breast Carcinoma Breast Carcinomas Carcinoma, Breast Carcinomas, Breast Mammary Neoplasms, Human Mammary Neoplasms, Human Human Mammary Neoplasm Human Mammary Neoplasms Neoplasm, Human Mammary Neoplasms, Human Mammary Mammary Neoplasm, Human Breast Cancer Breast Cancer Cancer, Breast Mammary Cancer Cancer, Mammary Cancers, Mammary Mammary Cancers Malignant Neoplasm of Breast Breast Malignant Neoplasm Breast Malignant Neoplasms Malignant Tumor of Breast Breast Malignant Tumor Breast Malignant Tumors Cancer of Breast Cancer of the Breast

Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Breast Neoplasms [C04.588.180]
Skin and Connective Tissue Diseases [C17]
Skin Diseases [C17.800]
Breast Diseases [C17.800.090]
Breast Neoplasms [C17.800.090.500]

Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Breast Neoplasms" by people in this website by year, and whether "Breast Neoplasms" was a major or minor topic of these publications.

Bar chart showing 2366 publications over 30 distinct years, with a maximum of 129 publications in 2010

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	18	1	19
1997	19	4	23
1998	19	3	22
1999	32	5	37
2000	34	9	43
2001	24	7	31
2002	51	12	63
2003	73	13	86
2004	71	9	80
2005	86	9	95
2006	77	7	84
2007	94	5	99
2008	94	13	107
2009	97	11	108
2010	119	10	129
2011	104	8	112
2012	98	13	111
2013	91	15	106
2014	90	10	100
2015	85	12	97
2016	107	11	118
2017	73	4	77
2018	100	7	107
2019	87	10	97
2020	86	4	90
2021	91	4	95
2022	85	2	87
2023	73	1	74
2024	55	5	60
2025	9	0	9

Below are the most recent publications written about "Breast Neoplasms" by people in Profiles.

Shames J, Nguyen A, Sciotto M, Zorn L, Kaufman T, Wilkes A, Sevrukov A, Kaushik C, Patel R, Pascarella S, Byrd A, Liao L. Can Contrast-Enhanced Mammography Improve Positive Predictive Value for Diagnostic Workup of Suspicious Findings? A Single-Arm Prospective Study. J Breast Imaging. 2025 May 17; 7(3):280-290.

View in: PubMed
Abdou Y, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF, Lin NU, Perez EA, Goldstein LJ, Chia SKL, Dhesy-Thind S, Rastogi P, Alba E, Delaloge S, Schott AF, Shak S, Sharma P, Lew DL, Miao J, Unger JM, Tripathy D, Hortobagyi GN, Pusztai L, Kalinsky K. Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial. J Natl Cancer Inst. 2025 May 01; 117(5):889-897.

View in: PubMed
Alam R, Reva A, Edwards DG, Lege BM, Munoz-Arcos LS, Reduzzi C, Singh S, Hao X, Wu YH, Tian Z, Natalee LM, Damle G, Demircioglu D, Wang Y, Wu L, Molteni E, Hasson D, Lim B, Gugala Z, Chipuk JE, Lang JE, Sparano JA, Cheng C, Cristofanilli M, Xiao H, Zhang XH, Bado IL. Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2- Breast Cancer. Cancer Discov. 2025 Apr 02; 15(4):818-837.

View in: PubMed
Roberts A, Campbell AC, Pollack BL, Montagna G, Sevilimedu V, Axelrod B, Gomez EA, Giri D, Morrow M, Mehrara BJ, Barrio AV. Racial and Ethnic Differences in Breast Inflammation and Its Association with Lymphedema Risk After Axillary Lymph Node Dissection. Ann Surg Oncol. 2025 May; 32(5):3309-3316.

View in: PubMed
Clemens MW, Mitchell MP, Christensen JM, Olenczak JB, Shay PL, Hanwright PJ, Ha AY, Kapur SK, Melancon AD, Shuck JW. Magnetic Resonance Imaging-Conditional Tissue Expanders in Breast Reconstruction: Clinical Outcomes and Radiation Therapy Implications. Plast Reconstr Surg. 2025 Aug 01; 156(2):225-233.

View in: PubMed
Podany EL, Foffano L, Gerratana L, Medford AJ, Clifton K, Tapiavala S, Velimirovic M, Lipsyc-Sharf M, Reduzzi C, Bubie A, Putur A, Ademuyiwa FO, Puglisi F, Gradishar WJ, Ma CX, Bardia A, Cristofanilli M, Davis AA. Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer. JAMA Netw Open. 2025 02 03; 8(2):e2461899.

View in: PubMed
Bakillah E, Brooks AD, Adekeye S. Switching to Tumescent Dissection in Mastectomy. Breast J. 2025; 2025:7634729.

View in: PubMed
Gharzai LA, Mady LJ, Armache M, Sun Z, Jagsi R, Cella D, Peipert JD, Sadigh G, Hass RW. Validation of a Single Item Measure for Financial Toxicity Screening in Patients With Breast Cancer. JCO Oncol Pract. 2025 Aug; 21(8):1134-1141.

View in: PubMed
Hrizat AS, Doxzon KA, O'Neill R, Post RP, Brachtel EF. Evaluation of HER2-Low breast carcinoma in metastatic settings: a cytological approach to proliferation and survival. J Am Soc Cytopathol. 2025 May-Jun; 14(3):182-190.

View in: PubMed
Leslie Salewon M, Pathak R, Dooley WC, Squires RA, Rui H, Chervoneva I, Tanaka T. Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-Medicare. Breast Cancer Res. 2024 Dec 30; 26(1):191.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement